Recent News

• 02.28.2025 - Avidity Biosciences Honors Rare Disease Day® and Global Efforts to Support People and Families Impacted by Rare Neuromuscular Diseases
• 02.27.2025 - Avidity Biosciences Reports Fourth Quarter 2024 Financial Results and Recent Highlights
• 02.25.2025 - Avidity Biosciences to Participate in Upcoming Investor Conferences
• 02.21.2025 - Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 01.20.2025 - Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 02.27.2025 - 8-K Current report
• 02.27.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.27.2025 - EX-99.1 EX-99.1
• 02.27.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2025 - 144 Report of proposed sale of securities
• 01.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.23.2025 - 4 Statement of changes in beneficial ownership of securities